Myelodysplastic syndromes: what we know about treatments people ask about
How far testing has got for each one in Myelodysplastic syndromes. This is what we know today, not advice.
How far testing has got
The step says how far testing has got, not that it works.
- Large trialsHigh-dose vitamin CTested in large studies that compare groups of patients. This says how far testing has got, not that it works.Phase 3 or randomised controlled trial on record. The rung shows the stage reached; the result is listed separately.
- Phase 2 trialsCannabis and cannabinoids (CBD, THC)Tested in medium-sized studies with patients, to see whether it does anything.Phase 2 or 2/3 trial on record.
- Phase 2 trialsCurcumin (turmeric)Tested in medium-sized studies with patients, to see whether it does anything.Phase 2 or 2/3 trial on record.
- Phase 2 trialsMelatoninTested in medium-sized studies with patients, to see whether it does anything.Phase 2 or 2/3 trial on record.
- Phase 2 trialsMetforminTested in medium-sized studies with patients, to see whether it does anything.Phase 2 or 2/3 trial on record.
- Phase 2 trialsStatinsTested in medium-sized studies with patients, to see whether it does anything.Phase 2 or 2/3 trial on record.
- First trials in peopleVitamin DFirst small studies in people, mainly to check safety and the dose.Phase 1, early Phase 1 or Phase 1/2 trial on record.
- Reports in peopleHyperthermiaSingle case reports or observations in people. These cannot show whether it helps.Case reports, observational data, or pooled data without a reported benefit.
Not medical advice. Talk to the care team before changing treatment. Thinking of paying for it? Read this first